Glenview’s Robbins Recommends AbbVie With Target of $90 by 2017
Alert: HALISTER Source: BN (Bloomberg News)
Tickers ABBV US (AbbVie Inc) 24379Z US (Glenview Capital Management LLC) BKD US (Brookdale Senior Living Inc) 4523 JP (Eisai Co Ltd)
People Lawrence Robbins (Glenview Capital Management LLC)
Topics Inflammatory Bowel Disease, Ulcerative Colitis
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283